|
1
|
Zieger K: High throughput molecular
diagnostics in bladder cancer - on the brink of clinical utility.
Mol Oncol. 1:384–394. 2008. View Article : Google Scholar
|
|
2
|
Jacobs BL, Lee CT and Montie JE: Bladder
cancer in 2010: How far have we come? CA Cancer J Clin. 60:244–272.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tian B, Wang Z, Zhao Y, Wang D, Li Y, Ma
L, Li X, Li J, Xiao N, Tian J, et al: Effects of curcumin on
bladder cancer cells and development of urothelial tumors in a rat
bladder carcinogenesis model. Cancer Lett. 264:299–308. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soloway MS, Sofer M and Vaidya A:
Contemporary management of stage T1 transitional cell carcinoma of
the bladder. J Urol. 167:1573–1583. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yuan X, Li T, Xiao E, et al: Licochalcone
B inhibits growth of bladder cancer cells by arresting cell cycle
progression and inducing apoptosis. Food Chem Toxicol. an
international journal published for the British Industrial
Biological Research Association. 65:242–251. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y, Zhang S, Geng JX and Hu XY: Curcumin
inhibits human non-small cell lung cancer A549 cell proliferation
through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J
Cancer Prev. 14:4599–4602. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li PM, Li YL, Liu B, Wang WJ, Wang YZ and
Li Z: Curcumin inhibits MHCC97H liver cancer cells by activating
ROS/TLR-4/caspase signaling pathway. Asian Pac J Cancer Prev.
15:2329–2334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim H, Tu HC, Ren D, Takeuchi O, Jeffers
JR, Zambetti GP, Hsieh JJ and Cheng EH: Stepwise activation of BAX
and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis.
Mol Cell. 36:487–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wen X, Lin ZQ, Liu B and Wei YQ:
Caspase-mediated programmed cell death pathways as potential
therapeutic targets in cancer. Cell Prolif. 45:217–224. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Diederich M: Natural Compounds and their
Role in Apoptotic Cell Signaling Pathways. 1171. Wiley-Blackwell;
Boston: pp. 1–660. 2009
|
|
13
|
Xiao XY, Hao M, Yang XY, Ba Q, Li M, Ni
SJ, Wang LS and Du X: Licochalcone A inhibits growth of gastric
cancer cells by arresting cell cycle progression and inducing
apoptosis. Cancer Lett. 302:69–75. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kwon SJ, Park SY, Kwon GT, Lee KW, Kang
YH, Choi MS, Yun JW, Jeon JH, Jun JG and Park JH: Licochalcone E
present in licorice suppresses lung metastasis in the 4T1 mammary
orthotopic cancer model. Cancer Prev Res (Phila). 6:603–613. 2013.
View Article : Google Scholar
|
|
15
|
Yuan X, Li D, Zhao H, Jiang J, Wang P, Ma
X, Sun X and Zheng Q: Licochalcone A-induced human bladder cancer
T24 cells apoptosis triggered by mitochondria dysfunction and
endoplasmic reticulum stress. BioMed Res Int. 2013:4742722013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dao TT, Nguyen PH, Lee HS, Kim E, Park J,
Lim SI and Oh WK: Chalcones as novel influenza A (H1N1)
neuraminidase inhibitors from Glycyrrhiza inflata. Bioorg Med Chem
Lett. 21:294–298. 2011. View Article : Google Scholar
|
|
17
|
Yoon G, Jung YD and Cheon SH: Cytotoxic
allyl retrochalcone from the roots of Glycyrrhiza inflata. Chem
Pharm Bull (Tokyo). 53:694–695. 2005. View Article : Google Scholar
|
|
18
|
Park EJ, Park HR, Lee JS and Kim J:
Licochalcone A: An inducer of cell differentiation and cytotoxic
agent from Pogostemon cablin. Planta Med. 64:464–466. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Franceschelli S, Pesce M, Vinciguerra I,
Ferrone A, Riccioni G, Patruno A, Grilli A, Felaco M and Speranza
L: Licocalchone-C extracted from Glycyrrhiza glabra inhibits
lipopolysaccharide-interferon-γ inflammation by improving
antioxidant conditions and regulating inducible nitric oxide
synthase expression. Molecules. 16:5720–5734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jung JI, Lim SS, Choi HJ, Cho HJ, Shin HK,
Kim EJ, Chung WY, Park KK and Park JH: Isoliquiritigenin induces
apoptosis by depolarizing mitochondrial membranes in prostate
cancer cells. J Nutr Biochem. 17:689–696. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hockenbery D, Nuñez G, Milliman C,
Schreiber RD and Korsmeyer SJ: Bcl-2 is an inner mitochondrial
membrane protein that blocks programmed cell death. Nature.
348:334–336. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kawai K, Miyazaki J, Joraku A, Nishiyama H
and Akaza H: Bacillus Calmette-Guerin (BCG) immunotherapy for
bladder cancer: Current understanding and perspectives on
engineered BCG vaccine. Cancer Sci. 104:22–27. 2013. View Article : Google Scholar
|
|
24
|
Silva SC, Wilson C and Woll PJ:
Bone-targeted agents in the treatment of lung cancer. Ther Adv Med
Oncol. 7:219–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Murray PJ, Wivell G and Denton E: Breast
cancer screening and diagnosis in the 21st century within the UK.
(Post Reprod Health). 23–Jul;2015.Epub ahead of print.
|
|
26
|
Hockenbery D, Nuñez G, Milliman C,
Schreiber RD and Korsmeyer SJ: Bcl-2 is an inner mitochondrial
membrane protein that blocks programmed cell death. Nature.
348:334–336. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Böhle A, Thanhäuser A, Ernst M, Flad HD,
Rüsch-Gerdes S, Jocham D and Ulmer AJ: Reduction of side effects of
intravesical therapy with bacille Calmette-Guérin by
pentoxifylline? - an in vitro approach. Clin Infect Dis. 31(Suppl
3): S101–S105. 2000. View
Article : Google Scholar
|
|
28
|
Hansel DE, McKenney JK, Stephenson AJ and
Chang SS: The Urinary Tract: A Comprehensive Guide to Patient
Diagnosis and Management. 32. Springer; New York: pp. 199–201.
2012
|
|
29
|
Kuno T, Tsukamoto T, Hara A and Tanaka T:
Cancer chemo-prevention through the induction of apoptosis by
natural compounds. J Biophys Chem. 03:156–173. 2012. View Article : Google Scholar
|
|
30
|
Safarzadeh E, Sandoghchian Shotorbani S
and Baradaran B: Herbal medicine as inducers of apoptosis in cancer
treatment. Advanced Pharml Bull. 4(Suppl 1): 421–427. 2014.
|
|
31
|
Oltersdorf T, Elmore SW, Shoemaker AR,
Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges
J, Hajduk PJ, et al: An inhibitor of Bcl-2 family proteins induces
regression of solid tumours. Nature. 435:677–681. 2005. View Article : Google Scholar : PubMed/NCBI
|
